EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Comprehensive Evidence for Mortality and Underlying Morbidity Related to Visceral Fat Distribution

Haolong Zhou, Danyang Ling, Qin Huang, Jiaojun Liang, Guanhua Su, Zhangbo Cui, Ziwei Chen, Xiaowen Ma, Zhou Jiang, Shuo Zheng, Haodong Tian, Qi Wang

Med Research · 2026-06 · 2 (2) · 214-226

DOI: 10.1002/mdr2.70055 ↗

At a glance

Journal article in Med Research, published online on 2026-02-10. Written by Haolong Zhou and 11 co-authors. Cited 2 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Linking obesity to mortality is an intriguing and controversial topic. This study tried to comprehensively assess 8 adiposity surrogates and mortality association among middle‐to‐old‐aged adults to identify a superior one, and explore explanatory disorders. Data sources included the National Health and Nutrition Examination Survey (NHANES), UK Biobank (UKB), and FinnGen R11. Cox proportional hazard model, restricted cubic spline, and Mendelian randomization (MR) were used to investigate adiposity surrogates and mortality associations. Observational and MR‐based phenome‐wide association studies (PheWASs) were performed to investigate explanatory disorders. Progressions of disease free‐disease‐death transition were assessed using multi‐state Markov (MSM) models. The NHANES and UKB analyses involved 11,706 and 352,980 participants, respectively. A body shape index (ABSI) showed consistent, stronger, and monotonically‐increasing associations with mortalities in both cohorts. MR analyses demonstrated a monotonically‐increasing causal effect of ABSI on all‐cause mortality (odds ratios [OR] = 1.370, 95% confidence interval [CI]: 1.119–1.676; P nonlinear = 0.269), which was greater than body mass index (OR = 1.279, 95% CI: 1.163–1.408; P nonlinear = 0.433). Two PheWASs identified 668 ABSI‐associated disorders, notably atherosclerosis, non‐alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and hypercholesterolemia. Markov models revealed ABSI's role in driving transitions from disease‐free to morbidity of the 4 diseases and death. ABSI, a visceral fat indicator, showed comparative competence in mortality evaluation. The adiposity‐mortality etiology involved diverse diseases across multiple systems, notably atherosclerosis, NAFLD, T2D, and hypercholesterolemia. These findings provide more evidence facilitating development and implementation of clinical guidelines for obesity assessment.

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhou, H., Ling, D., Huang, Q., Liang, J., Su, G., Cui, Z., Chen, Z., Ma, X., Jiang, Z., Zheng, S., Tian, H., & Wang, Q. (2026). Comprehensive Evidence for Mortality and Underlying Morbidity Related to Visceral Fat Distribution. Med Research, 2(2), 214-226. https://doi.org/10.1002/mdr2.70055

Vancouver

Zhou H, Ling D, Huang Q, Liang J, Su G, Cui Z, et al. Comprehensive Evidence for Mortality and Underlying Morbidity Related to Visceral Fat Distribution. Med Research. 2026;2(2):214-226. doi:10.1002/mdr2.70055

BibTeX
@article{Zhou2026,
  author = {Zhou, Haolong and Ling, Danyang and Huang, Qin and Liang, Jiaojun and Su, Guanhua and Cui, Zhangbo and Chen, Ziwei and Ma, Xiaowen and Jiang, Zhou and Zheng, Shuo and Tian, Haodong and Wang, Qi},
  title = {Comprehensive Evidence for Mortality and Underlying Morbidity Related to Visceral Fat Distribution},
  journal = {Med Research},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {214--226},
  doi = {10.1002/mdr2.70055}
}
Start for free →